Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Goodwill (2016 - 2019)

Ironwood Pharmaceuticals' Goodwill history spans 4 years, with the latest figure at $785000.0 for Q4 2019.

  • On a quarterly basis, Goodwill changed 0.0% to $785000.0 in Q4 2019 year-over-year; TTM through Dec 2019 was $785000.0, a 0.0% change, with the full-year FY2019 number at $785000.0, changed 0.0% from a year prior.
  • Goodwill hit $785000.0 in Q4 2019 for Ironwood Pharmaceuticals, roughly flat from $785000.0 in the prior quarter.
  • Over the last five years, Goodwill for IRWD hit a ceiling of $785000.0 in Q4 2016 and a floor of $649000.0 in Q2 2016.
  • Historically, Goodwill has averaged $766866.7 across 4 years, with a median of $785000.0 in 2016.
  • The widest YoY moves for Goodwill: up 20.96% in 2017, down 0.0% in 2017.
  • Tracing IRWD's Goodwill over 4 years: stood at $785000.0 in 2016, then changed by 0.0% to $785000.0 in 2017, then changed by 0.0% to $785000.0 in 2018, then changed by 0.0% to $785000.0 in 2019.
  • Business Quant data shows Goodwill for IRWD at $785000.0 in Q4 2019, $785000.0 in Q3 2019, and $785000.0 in Q2 2019.